MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 21, Issue 4, 2008, Pages 335-341

  Martin, Andrew R ^a   Thompson, Richard B ^a   Finlay, Warren H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Lung deposition; Magnetic resonance imaging; Mice; nose only inhalation; MRI; SPIONs; Superparamagnetic iron oxide nanoparticles

Indexed keywords

CONTRAST MEDIUM; IRON OXIDE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GEOMETRY; IN VIVO STUDY; LUNG PARENCHYMA; MOUSE; NEBULIZER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; AEROSOLS; ANIMALS; DRUG DELIVERY SYSTEMS; FEMALE; FERRIC COMPOUNDS; LUNG; MAGNETIC RESONANCE IMAGING; MAGNETICS; MICE; MICE, INBRED BALB C; NANOPARTICLES; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; TISSUE DISTRIBUTION;

EID: 57149097147     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2008.0698     Document Type: Article

References (22)

1. Coates AL: Guiding aerosol deposition in the lung. N Engl J Med. 2008;358:304-305.
2. Plank C: Nanomagnetosols: magnetism opens up new perspectives for targeted aerosol delivery to the lung. Trends Biotechnol. 2008;26:59-63.
3. Dames P, Gleich B, Flemmer A, Hajek K, Seidl N, Wiekhorst F, Eberbeck D, Bittmann I, Bergemann C, Weyh T, Trahms L, Rosenecker J, and Rudolph C: Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol. 2007;2:495-499.
4. Martin AR, and Finlay WH: Alignment of magnetite loaded high aspect ratio aerosol drug particles with magnetic fields. Aerosol Sci Technol. 2008;42:245-248.
5. Shang YH, Finlay WH, and Moussa WA: Numerical analysis of thermally induced micro fiber deformation using a high frequency magnetic field in human lung. J Comp Theor Nanosci 2008;5:294-301.
6. Weinmann H-J, Ebert W, Misselwitz B, and Schmitt-Willich H: Tissure-specific MR contrast agents. Eur J Radiol. 2003;46:33-44.
7. Bellin M-F. MR contrast agents, the old and the new. Eur J Radiol 2006;60:314-323.
8. Lemke A-J, von Pilsach MIS, Lubbe A, Bergemann C, Riess H, and Felix R: MRI after magnetic drug targeting in patients with advanced solid malignant tumors. Eur Radiol. 2004;14:1949-1955.
9. Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, and Yang VC: Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 2008;29:487-496.
10. Sood BG, Shen Y, Latif Z, Chen X, Sharp J, Neelavalli J, Joshi A, Slovis TL, and Haacke EM: Aerosol delivery in ventilated newborn pigs: an MRI evaluation. Pediatr Res. in press.
11. Phalen RF, Oldham MJ, and Wolff RK: The relevance of animal models for aerosol studies. J Aerosol Med. 2008;21:113-124.
12. Nadithe V, Rahamatalla M, Finlay WH, Mercer JR, and Samuel J: Evaluation of nose-only aerosol inhalation chamber and comparison of experimental results with mathematical simulation of aerosol deposition in mouse lungs. J Pharm Sci. 2003;92:1066-1076.
13. Rosenthal SG, Willich HC, Ebert W, and Conrad J: The demonstration of human tumors on nude mice using gadolinium-labeled monoclonal antibodies for magnetic resonance imaging. Invest Radiol. 1993;28:789-793.
14. Suwa T, Ozawa S, Ueda M, Ando N, and Kitajima M: Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody. Int J Cancer. 1998;75:626-634.
15. Costa DL, Lehmann JR, Winsett D, Richards J, Ledbetter AD, and Dreher KL: Comparative pulmonary toxicological assessment of oil combustion particles following inhalation or instillation exposure. Toxicol Sci. 2006;91:237-246.
16. 1-maps during oxygen enhancement. MAGMA. 2004;16:246-253.
17. Stadler A, Jakob PM, Griswold M, Stiebellehner L, Barth M, and Bankier AA: T1 mapping of the entire lung parenchyma: Influence of respiratory phase and correlation to lung function test results in patients with diffuse lung disease. Magn. Reson. Med. 008;59:96-101.
18. Fleming JS, Quint M, Bolt L, Martonen TB, and Conway JH: Comparison of SPECT aerosol deposition data with twenty-four-hour clearance measurements. J Aerosol Med. 2006;19:261-267.
19. Lindstrom M, Camner P, Falk R, Hjelte L, Philipson K, and Svartengren M: Long-term clearance from small airways in patients with cystic fibrosis. Eur Respir J. 2005;25:317-323.
20. Falk R, Philipson K, Svartengren M, Bergmann R, Hofmann W, Jarvis N, Bailey M, and Camner P: Assesment of long-term bronchiolar clearance of particles from measurements of lung retention and theoretical estimates of regional deposition. Exp Lung Res. 1999;25:495-516.
21. Möller W, Häubinger K, Winkler-Heil R, Stahlhofen W, Meyer T, Hofmann W, and Heyder J: Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects. J Appl Physiol. 2004;97:2200-2206.
22. Möller W, Häubinger K, Ziegler-Heitbrock L, and Heyder J: Mucociliary and long-term particle clearance in airways of patients with immotile cilia. Respir Res. 2006;7:10.